Inventiva (IVA) Payables (2018 - 2025)
Inventiva (IVA) recorded quarterly Payables of $30.3 million in Q4 2025, down 99.93% quarter-over-quarter from $45.5 billion in Q2 2025, and down 99.52% on a YoY basis from $6.3 billion in Q4 2024.
Inventiva (IVA) Payables (2018 - 2025) Analysis & Trends
Inventiva's Payables history runs 8 years deep, the most recent figure standing at $30.3 million for Q4 2025.
- In Q4 2025, Payables fell 99.52% year-over-year to $30.3 million; the TTM figure through Dec 2025 stood at $30.3 million (down 99.52% YoY), while the FY2025 annual figure was $30.3 million, down 99.52% from the prior year.
- Payables was $30.3 million for Q4 2025 at Inventiva, down from $45.5 billion in the prior quarter.
- In the past five years, Payables ranged from a high of $45.5 billion in Q2 2025 to a low of $10.4 million in Q4 2023.
- Historically, Payables has averaged $6.2 billion across 5 years, with a median of $39.1 million in 2023.
- The sharpest annual moves came in 2022 and 2023: Payables jumped 167981.2% in 2022, then plunged 99.82% in 2023.
- A 5-year view of Payables shows it stood at $1.5 billion in 2021, then plunged by 98.67% to $19.8 million in 2022, then soared by 105.26% to $40.5 million in 2023, then surged by 15453.97% to $6.3 billion in 2024, then tumbled by 99.52% to $30.3 million in 2025.
- The last three Payables figures came in at $30.3 million (Q4 2025), $45.5 billion (Q2 2025), and $6.3 billion (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 300,549.00 |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 8.69 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 34.55 Mn |
| 10 | Inventiva | 8.93 Mn | -259.80 Mn | - | 30.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 30.28 Mn |
| Jun 30, 2025 | 45.55 Bn |
| Dec 31, 2024 | 6.31 Bn |
| Jun 30, 2024 | 46.74 Mn |
| Dec 31, 2023 | 40.54 Mn |
| Oct 11, 2023 | 10.40 Mn |
| Jun 30, 2023 | 37.61 Mn |
| Dec 31, 2022 | 19.75 Mn |
| Jun 30, 2022 | 20.64 Bn |
| Dec 31, 2021 | 1.48 Bn |
| Jun 30, 2021 | 12.28 Mn |
| Mar 31, 2021 | 10.50 Mn |
| Dec 31, 2020 | 8.28 Mn |
| Jun 30, 2020 | 20.44 Mn |
| Dec 31, 2019 | 8.42 Mn |
| Dec 31, 2018 | 9.73 Mn |